210 related articles for article (PubMed ID: 11514908)
1. Prevention of respiratory syncytial virus infections.
Bricks LF
Rev Hosp Clin Fac Med Sao Paulo; 2001; 56(3):79-90. PubMed ID: 11514908
[TBL] [Abstract][Full Text] [Related]
2. Prevention strategies for respiratory syncytial virus: passive and active immunization.
Englund JA
J Pediatr; 1999 Aug; 135(2 Pt 2):38-44. PubMed ID: 10431138
[TBL] [Abstract][Full Text] [Related]
3. Passive and active immunization against respiratory syncytial virus for the young and old.
Villafana T; Falloon J; Griffin MP; Zhu Q; Esser MT
Expert Rev Vaccines; 2017 Jul; 16(7):1-13. PubMed ID: 28525961
[TBL] [Abstract][Full Text] [Related]
4. Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. The Respiratory Syncytial Virus Immune Globulin Study Group.
Groothuis JR; Simoes EA; Levin MJ; Hall CB; Long CE; Rodriguez WJ; Arrobio J; Meissner HC; Fulton DR; Welliver RC
N Engl J Med; 1993 Nov; 329(21):1524-30. PubMed ID: 8413475
[TBL] [Abstract][Full Text] [Related]
5. Palivizumab in the prophylaxis of respiratory syncytial virus infection.
Cardenas S; Auais A; Piedimonte G
Expert Rev Anti Infect Ther; 2005 Oct; 3(5):719-26. PubMed ID: 16207163
[TBL] [Abstract][Full Text] [Related]
6. Revised indications for the use of palivizumab and respiratory syncytial virus immune globulin intravenous for the prevention of respiratory syncytial virus infections.
Meissner HC; Long SS;
Pediatrics; 2003 Dec; 112(6 Pt 1):1447-52. PubMed ID: 14654628
[TBL] [Abstract][Full Text] [Related]
7. Revised indications for the use of palivizumab and respiratory syncytial virus immune globulin intravenous for the prevention of respiratory syncytial virus infections.
American Academy of Pediatrics Committee on Infectious Diseases and Committee on Fetus and Newborn
Pediatrics; 2003 Dec; 112(6 Pt 1):1442-6. PubMed ID: 14654627
[TBL] [Abstract][Full Text] [Related]
8. Advances in and the potential of vaccines for respiratory syncytial virus.
Jorquera PA; Oakley KE; Tripp RA
Expert Rev Respir Med; 2013 Aug; 7(4):411-27. PubMed ID: 23964629
[TBL] [Abstract][Full Text] [Related]
9. Antibodies for prevention and treatment of respiratory syncytial virus infections in children.
Geevarghese B; Simões EA
Antivir Ther; 2012; 17(1 Pt B):201-11. PubMed ID: 22311607
[TBL] [Abstract][Full Text] [Related]
10. Immunoglobulin for preventing respiratory syncytial virus infection.
Wang EE; Tang NK
Cochrane Database Syst Rev; 2000; (2):CD001725. PubMed ID: 10796658
[TBL] [Abstract][Full Text] [Related]
11. Prevention of respiratory syncytial virus infections: indications for the use of palivizumab and update on the use of RSV-IGIV. American Academy of Pediatrics Committee on Infectious Diseases and Committee of Fetus and Newborn.
Pediatrics; 1998 Nov; 102(5):1211-6. PubMed ID: 9794957
[TBL] [Abstract][Full Text] [Related]
12. Value profile for respiratory syncytial virus vaccines and monoclonal antibodies.
Fleming JA; Baral R; Higgins D; Khan S; Kochar S; Li Y; Ortiz JR; Cherian T; Feikin D; Jit M; Karron RA; Limaye RJ; Marshall C; Munywoki PK; Nair H; Newhouse LC; Nyawanda BO; Pecenka C; Regan K; Srikantiah P; Wittenauer R; Zar HJ; Sparrow E
Vaccine; 2023 Nov; 41 Suppl 2():S7-S40. PubMed ID: 37422378
[TBL] [Abstract][Full Text] [Related]
13. Current progress on development of respiratory syncytial virus vaccine.
Chang J
BMB Rep; 2011 Apr; 44(4):232-7. PubMed ID: 21524347
[TBL] [Abstract][Full Text] [Related]
14. Respiratory syncytial virus vaccine development.
Kahn JS
Curr Opin Pediatr; 2000 Jun; 12(3):257-62. PubMed ID: 10836163
[TBL] [Abstract][Full Text] [Related]
15. Current strategies and perspectives for active and passive immunization against Respiratory Syncytial Virus in childhood.
Scotta MC; Stein RT
J Pediatr (Rio J); 2023; 99 Suppl 1(Suppl 1):S4-S11. PubMed ID: 36402228
[TBL] [Abstract][Full Text] [Related]
16. Assessing the Real-World Effectiveness of Immunizations for Respiratory Syncytial Virus.
Dawood FS; Payne AB; McMorrow ML
JAMA; 2024 Jun; 331(21):1799-1800. PubMed ID: 38602685
[TBL] [Abstract][Full Text] [Related]
17. Vaccines against respiratory syncytial virus: The time has finally come.
Graham BS
Vaccine; 2016 Jun; 34(30):3535-41. PubMed ID: 27182820
[TBL] [Abstract][Full Text] [Related]
18. Respiratory syncytial virus immunoglobulin and monoclonal antibodies in the prevention and treatment of respiratory syncytial virus infection.
Welliver RC
Semin Perinatol; 1998 Feb; 22(1):87-95. PubMed ID: 9523402
[TBL] [Abstract][Full Text] [Related]
19. Respiratory syncytial virus vaccine: where are we now and what comes next?
Noor A; Krilov LR
Expert Opin Biol Ther; 2018 Dec; 18(12):1247-1256. PubMed ID: 30426788
[TBL] [Abstract][Full Text] [Related]
20. Respiratory syncytial virus: old challenges and new approaches.
Chávez-Bueno S; Mejías A; Jafri HS; Ramilo O
Pediatr Ann; 2005 Jan; 34(1):62-8. PubMed ID: 15693217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
